The ITIM-containing receptor LAIR1 is essential for acute myeloid leukaemia development

Nature Cell Biology

Volumn 17, Issue 5, 2015, Pages 665-677

  Kang, Xunlei ^a   Lu, Zhigang ^a   Cui, Changhao ^a,g   Deng, Mi ^a   Fan, Yuqi ^a   Dong, Baijun ^b   Han, Xin ^b   Xie, Fuchun ^c   Tyner, Jeffrey W ^d   Coligan, John E ^e   Collins, Robert H ^f   Xiao, Xiangshu ^c   You, M James ^b   Zhang, Cheng Cheng ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^f UNIVERSITY OF TEXAS   (United States)

^g DALIAN UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE I; LAIR1 PROTEIN; PROTEIN TYROSINE PHOSPHATASE SHP 1; TUMOR PROTEIN; UNCLASSIFIED DRUG; CAMK1 PROTEIN, HUMAN; CREB1 PROTEIN, HUMAN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; IMMUNOGLOBULIN RECEPTOR; LEUKOCYTE-ASSOCIATED IMMUNOGLOBULIN-LIKE RECEPTOR 1; PTPN6 PROTEIN, HUMAN;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER STEM CELL; CELL RENEWAL; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN CELL; LEUKEMIA CELL; MALE; MIDDLE AGED; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; YOUNG ADULT; ANIMAL; C57BL MOUSE; CELL PROLIFERATION; DEFICIENCY; GENETIC TRANSFECTION; GENETICS; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PROTEIN MOTIF; RNA INTERFERENCE; TIME; TUMOR CELL CULTURE; TUMOR CELL LINE;

ADULT; AGED; AMINO ACID MOTIFS; ANIMALS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 1; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; FEMALE; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; MIDDLE AGED; NEOPLASTIC STEM CELLS; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 6; RECEPTORS, IMMUNOLOGIC; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED; YOUNG ADULT;

EID: 84928938594     PISSN: 14657392     EISSN: 14764679     Source Type: Journal    
DOI: 10.1038/ncb3158     Document Type: Article

References (56)

1. Maynadie M., et al. Twenty-five years of epidemiological recording on myeloid malignancies: data from the specialized registry of hematologic malignancies of Cote d'Or (Burgundy France). Haematologica 96, 55-61 (2011
2. Krause D. S. & Van Etten R. A. Right on target: eradicating leukemic stem cells. Trends Mol. Med. 13, 470-481 (2007
3. Lapidot T., et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367, 645-648 (1994
4. Lane S. W., Scadden D. T. & Gilliland D. G. The leukemic stem cell niche: current concepts and therapeutic opportunities. Blood 114, 1150-1157 (2009
5. Wei J., et al. Microenvironment determines lineage fate in a human model of MLLAF9 leukemia. Cancer Cell 13, 483-495 (2008
6. Ishikawa F., et al. Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region. Nat. Biotechnol. 25, 1315-1321 (2007
7. Imbesi S., et al. Oxidative stress in oncohematologic diseases: an update. Expert Rev. Hematol. 6, 317-325 (2013
8. Fathi A. & Levis M. FLT3 inhibitors: a story of the old and the new. Curr. Opin. Hematol. 18, 71-76 (2011
9. Vainchenker W. & Constantinescu S. N. JAK/STAT signaling in hematological malignancies. Oncogene 32, 2601-2613 (2013
10. Broxmeyer H. E. Chemokines in hematopoiesis. Curr. Opin. Hematol. 15, 49-58 (2008
11. Jin L., Hope K. J., Zhai Q., Smadja-Joffe F. & Dick J. E. Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nat. Med. 12, 1167-1174 (2006
12. Krause D. S., Lazarides K., von Andrian U. H. & Van Etten R. A. Requirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cells. Nat. Med. 12, 1175-1180 (2006
13. Miller P. G., et al. In vivo RNAi screening identifies a leukemia-specific dependence on integrin beta 3 signaling. Cancer Cell 24, 45-58 (2013
14. Chao M. P., et al. Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma. Cell 142, 699-713 (2010
15. Jan M., et al. Prospective separation of normal and leukemic stem cells based on differential expression of TIM3, a human acute myeloid leukemia stem cell marker. Proc. Natl Acad. Sci. USA 108, 5009-5014 (2011
16. Horton S. J. & Huntly B. J. Recent advances in acute myeloid leukemia stem cell biology. Haematologica 97, 966-974 (2012
17. Weng A. P., et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 306, 269-271 (2004
18. Zhao C., et al. Loss of beta-Catenin impairs the renewal of normal and CML stem cells in vivo. Cancer Cell 12, 528-541 (2007
19. Wang Y., et al. The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML. Science 327, 1650-1653 (2010
20. Zhao C., et al. Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature 458, 776-779 (2009
21. Krause D. S., et al. Differential regulation of myeloid leukemias by the bone marrow microenvironment. Nat. Med. 19, 1513-1517 (2013
22. Heidel F. H., Mar B. G. & Armstrong S. A. Self-renewal related signaling in myeloid leukemia stem cells. Int. J. Hematol. 94, 109-117 (2011
23. Konopleva M. Y. & Jordan C. T. Leukemia stem cells and microenvironment: biology and therapeutic targeting. J. Clin. Oncol. 29, 591-599 (2011
24. Sands W. A., Copland M. & Wheadon H. Targeting self-renewal pathways in myeloid malignancies. Cell Commun. Signal 11, 33 (2013
25. Zheng J., et al. Inhibitory receptors bind Angptls and support blood stem cells and leukemia development. Nature 485, 656-660 (2012
26. Takai T., Nakamura A. & Endo S. Role of PIR-B in autoimmune glomerulonephritis. J. Biomed. Biotechnol. 2011, 275302 (2011
27. Daeron M., Jaeger S., Du Pasquier L. & Vivier E. Immunoreceptor tyrosine-based inhibition motifs: a quest in the past and future. Immunol. Rev. 224, 11-43 (2008
28. Kim T., et al. Human LilrB2 is a beta-amyloid receptor and its murine homolog PirB regulates synaptic plasticity in an Alzheimer's model. Science 341, 1399-1404 (2013
29. Tang X., et al. Leukocyte-associated Ig-like receptor-1-deficient mice have an altered immune cell phenotype. J. Immunol. 188, 548-558 (2012
30. Olde Nordkamp M. J., et al. Leukocyte-associated Ig-like receptor-1 is a novel inhibitory receptor for surfactant protein D. J. Leukoc. Biol. 96, 105-111 (2014
31. Meyaard L. LAIR and collagens in immune regulation. Immunol. Lett. 128, 26-28 (2010
32. Maasho K., et al. The inhibitory leukocyte-associated Ig-like receptor-1 (LAIR-1) is expressed at high levels by human naive T cells and inhibits TCR mediated activation. Mol. Immunol. 42, 1521-1530 (2005
33. Krivtsov A. V., et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature 442, 818-822 (2006
34. Somervaille T. C. & Cleary M. L. Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia. Cancer Cell 10, 257-268 (2006
35. Yan M., et al. A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis. Nat. Med. 12, 945-949 (2006
36. Sugihara E., et al. Ink4a and Arf are crucial factors in the determination of the cell of origin and the therapeutic sensitivity of Myc-induced mouse lymphoid tumor. Oncogene 31, 2849-2861 (2012
37. Tapley P., et al. Increased G-CSF responsiveness of bone marrow cells from hematopoietic cell phosphatase deficient viable motheaten mice. Exp. Hematol. 25, 122-131 (1997
38. Paulson R. F., Vesely S., Siminovitch K. A. & Bernstein A. Signalling by the W/Kit receptor tyrosine kinase is negatively regulated in vivo by the protein tyrosine phosphatase Shp1. Nat. Genet. 13, 309-315 (1996
39. Lorenz U., et al. Genetic analysis reveals cell type-specific regulation of receptor tyrosine kinase c-Kit by the protein tyrosine phosphatase SHP1. J. Exp. Med. 184, 1111-1126 (1996
40. Timms J. F., et al. Identification of major binding proteins and substrates for the SH2- containing protein tyrosine phosphatase SHP-1 in macrophages. Mol. Cell. Biol. 18, 3838-3850 (1998
41. Minoo P., Zadeh M. M., Rottapel R., Lebrun J. J. & Ali S. A novel SHP- 1/Grb2-dependent mechanism of negative regulation of cytokine-receptor signaling: contribution of SHP-1 C-terminal tyrosines in cytokine signaling. Blood 103, 1398-1407 (2004
42. Xu M., Zhao R. & Zhao Z. J. Identification and characterization of leukocyteassociated Ig-like receptor-1 as a major anchor protein of tyrosine phosphatase SHP-1 in hematopoietic cells. J. Biol. Chem. 275, 17440-17446 (2000
43. Shankar D. B., et al. The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia. Cancer Cell 7, 351-362 (2005
44. Liu F., Thompson M. A., Wagner S., Greenberg M. E. & Green M. R. Activating transcription factor-1 can mediate Ca(2C)- and cAMP-inducible transcriptional activation. J. Biol. Chem. 268, 6714-6720 (1993
45. Tyson D. R., Swarthout J. T., Jefcoat S. C. & Partridge N. C. PTH induction of transcriptional activity of the cAMP response element-binding protein requires the serine 129 site and glycogen synthase kinase-3 activity but not casein kinase II sites. Endocrinology 143, 674-682 (2002
46. Xiao X., Li B. X. & Xie F. Pharmaceutical Compositions Comprising Naphthamides As Antitumor Agents WO 2013067379 (2012
47. Li B. X. & Xiao X. Discovery of a small-molecule inhibitor of the KIX-KID interaction. Chembiochem 10, 2721-2724 (2009
48. Eklund E. A., Goldenberg I., Lu Y., Andrejic J. & Kakar R. SHP1 protein-tyrosine phosphatase regulates HoxA10 DNA binding and transcriptional repression activity in undifferentiated myeloid cells. J. Biol. Chem. 277, 36878-36888 (2002
49. Tibaldi E., et al. Lyn-mediated SHP-1 recruitment to CD5 contributes to resistance to apoptosis of B-cell chronic lymphocytic leukemia cells. Leukemia 25, 1768-1781 (2011
50. Shultz L. D., et al. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell 73, 1445-1454 (1993
51. Picciotto M. R., Zoli M., Bertuzzi G. & Nairn A. C. Immunochemical localization of calcium/calmodulin-dependent protein kinase I. Synapse 20, 75-84 (1995
52. Stedman D. R., Uboha N. V., Stedman T. T., Nairn A. C. & Picciotto M. R. Cytoplasmic localization of calcium/calmodulin-dependent protein kinase I-alpha depends on a nuclear export signal in its regulatory domain. FEBS Lett. 566, 275-280 (2004
53. Zhang C. C., Kaba M., Iizuka S., Huynh H. & Lodish H. F. Angiopoietinlike 5 and IGFBP2 stimulate ex vivo expansion of human cord blood hematopoietic stem cells as assayed by NOD/SCID transplantation. Blood 111, 3415-3423 (2008
54. Zheng J., et al. Ex vivo expanded hematopoietic stem cells overcome the MHC barrier in allogeneic transplantation. Cell Stem Cell 9, 119-130 (2011
55. Huynh H., et al. IGF binding protein 2 supports the survival and cycling of hematopoietic stem cells. Blood 118, 3236-3243 (2011
56. Zheng J., Huynh H., Umikawa M., Silvany R. & Zhang C. C. Angiopoietin-like protein 3 supports the activity of hematopoietic stem cells in the bone marrow niche. Blood 117, 470-479 (2011